The CAR T Cell Therapy Market is estimated to be valued at US$2.26 billion in 2022 and is expected to exhibit a CAGR of 20.9% over the forecast period 2022-2030, as highlighted in a new report publish
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |